microdose glp-1 noom What if you could start smaller…and still move forward? Microdosing can offer a more personalized approach to GLP-1s, using less, but with intention. Small shifts. Real impact. Tap through to learn more GLP-1 works with your biology

Experts estimate its first potential FDA approval for obesity and type 2 diabetes treatment sometime in late 2026 or early 2027

Food and Drug Administration (FDA) hasnt approved any weight loss patches that work like the blockbuster injected GLP-1 drugs Ozempic, Wegovy, Zepbound, and Mounjaro, says Jody Dushay, MD, an assistant professor at Harvard Medical School and an endocrinologist at Beth Israel Deaconess Medical Center in Boston

Surgery is invasive, Low Wang said

If youre experiencing ongoing fatigue, decreased appetite, or any side effects, our team is here to listen and help

These medications have undergone extensive clinical trials to evaluate their efficacy and safety in managing type 2 diabetes and, more recently, their potential for weight loss